Mezoo
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Mezoo makes medical devices that continuously track patients' vital signs, such as heart rate, blood oxygen, and blood pressure, and transmit that data wirelessly to clinicians, allowing doctors and nurses to monitor patients in real time from a central station or remotely.
Its products range from bedside patient monitors and central monitoring systems to wearable adhesive patches that record heart activity over extended periods, serving hospitals and other clinical settings. Listed on KOSDAQ, Korea's tech-focused small-cap exchange, the company's portfolio spans both in-hospital monitoring hardware and ambulatory remote patient monitoring solutions for patients who are mobile rather than confined to a bed.
Summary is AI-generated and may contain errors · figures from DART filings
Mezoo in five facts
What does Mezoo do?
Mezoo makes medical devices that continuously track patients' vital signs, such as heart rate, blood oxygen, and blood pressure, and transmit that data wirelessly to clinicians, allowing doctors and nurses to monitor patients in real time from a central station or remotely.
Where is Mezoo listed and in which sector?
Mezoo (Korean name: 메쥬) trades under KRX code 0088M0 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Medical Devices.
How large is Mezoo?
Its market capitalisation was US$101.9M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Mezoo's latest annual revenue and operating profit?
For fiscal year 2025, Mezoo reported revenue of US$5.6M, an operating loss of US$2.1M and net income of US$2.1M, per its annual report on DART (data retrieved from DART on 2026-10-02).
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-10-02
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Material event reportSep 30
- Operating results (preliminary) (fair disclosure)
Mezoo filed provisional (unaudited) separate results for Q2 2026: revenue of US$3.93M (+104.2% year on year), operating profit of US$607K (+73% year on year) and net income of US$761K (+333.9% year on year).
Earnings · Jul 29 - Operating results (preliminary) (fair disclosure)
Mezoo filed provisional (unaudited) separate results for Q1 2026: revenue of US$2.65M (+1416.5% year on year), operating profit of US$649K (from a loss a year earlier) and net income of US$648K (from a loss a year earlier).
Earnings · Apr 30